Literature DB >> 19341908

Why an alternative to blood transfusion?

Aryeh Shander1, Lawrence Tim Goodnough.   

Abstract

Allogeneic blood transfusions have been associated with several risks and complications and with worse outcomes in a substantial number of patient populations and clinical scenarios. Allogeneic blood is costly and difficult to procure, transport, and store. Global and local shortages are imminent. Alternatives to transfusion provide many advantages, and their use is likely to improve outcomes as safer and more effective agents are developed.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19341908     DOI： 10.1016/j.ccc.2008.12.012

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN： 0749-0704            Impact factor:   3.598


  17 in total

1.  Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04-20       Impact factor: 3.443

Review 2.  [Cell salvage : Scientific evidence, clinical practice and legal framework].

Authors:  T Seyfried; E Hansen
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

3.  Preanesthetic Assessment of the Jehovah's Witness Patient.

Authors:  Eric S Lin; Alan D Kaye; Amir R Baluch
Journal:  Ochsner J       Date:  2012

Review 4.  [Perioperative management of Jehovah's Witness patients. Special consideration of religiously motivated refusal of allogeneic blood transfusion].

Authors:  O Habler; B Voss
Journal:  Anaesthesist       Date:  2010-04       Impact factor: 1.041

5.  Patient blood management implementation strategies and their effect on physicians' risk perception, clinical knowledge and perioperative practice - the frankfurt experience.

Authors:  Dania P Fischer; Kai D Zacharowski; Markus M Müller; Christof Geisen; Erhard Seifried; Heiko Müller; Patrick Meybohm
Journal:  Transfus Med Hemother       Date:  2015-03-12       Impact factor: 3.747

Review 6.  Preserving human cells for regenerative, reproductive, and transfusion medicine.

Authors:  Waseem Asghar; Rami El Assal; Hadi Shafiee; Raymond M Anchan; Utkan Demirci
Journal:  Biotechnol J       Date:  2014-07       Impact factor: 4.677

7.  Perioperative blood transfusion affects hepatitis C virus (HCV)-specific immune responses and outcome following liver transplantation in HCV-infected patients.

Authors:  Vijay Subramanian; Ankit Bharat; Neeta Vachharajani; Jeffrey Crippin; Surendra Shenoy; Thalachallour Mohanakumar; William C Chapman
Journal:  HPB (Oxford)       Date:  2013-07-22       Impact factor: 3.647

8.  Patient blood management in Europe.

Authors:  A Shander; H Van Aken; M J Colomina; H Gombotz; A Hofmann; R Krauspe; S Lasocki; T Richards; R Slappendel; D R Spahn
Journal:  Br J Anaesth       Date:  2012-05-24       Impact factor: 9.166

Review 9.  Physician autonomy and patient rights: lessons from an enforced blood transfusion and the role of patient blood management.

Authors:  Matteo Bolcato; Aryeh Shander; James P Isbister; Kevin M Trentino; Marianna Russo; Daniele Rodriguez; Anna Aprile
Journal:  Vox Sang       Date:  2021-04-07       Impact factor: 2.996

10.  The impact of an algorithm-guided management of preoperative anemia in perioperative hemoglobin level and transfusion of major orthopedic surgery patients.

Authors:  Dietmar Enko; Franz Wallner; Achim von-Goedecke; Christa Hirschmugl; Vinzenz Auersperg; Gabriele Halwachs-Baumann
Journal:  Anemia       Date:  2013-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.